ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1051

Magnetic Resonance Imaging in Inflammatory Bowel Disease Patients with Arthralgia

W. Stomp1, L.K.P.M. Brakenhoff2, F.a. van Gaalen3, D. van der Heijde4, H.H. Fidder5, D.W. Hommes6, M. Reijnierse1 and J.L Bloem1, 1Radiology, Leiden University Medical Center, Leiden, Netherlands, 2Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, Netherlands, 3Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 4Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 5Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, Netherlands, 6Center for Inflammatory Bowel Diseases, University of California Los Angeles, Los Angeles, CA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Inflammation, inflammatory arthritis, inflammatory bowel disease (IBD) and magnetic resonance imaging (MRI)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Imaging of Rheumatic Diseases: Magnetic Resonance Imaging, Computed Tomography and X-ray

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Joint manifestations frequently occur in chronic inflammatory bowel diseases (IBD). Arthralgia, non-inflammatory joint pain without objective evidence of swelling or effusion, is present in 8-30% of all patients.(1-3) An underlying cause of arthralgia in IBD patients is not known and might be autoimmune related, which might express on MR as bone marrow edema. The purpose of this study is to assess whether inflammatory changes, including bone marrow edema can be detected on MRI in IBD patients  with joint pain without clinical synovitis.

Methods:

The most painful peripheral joint, without clinical signs of inflammation based on examination by a rheumatologist, at most 2 weeks prior to MR, was scanned in 14 IBD patients (11 Crohn’s disease/3 ulcerative colitis) on a 1.5T extremity MRI. In addition the same joints were scanned in a control group of 14 IBD patients who were matched for form of IBD, disease duration, sex and age without joint complaints. MR imaging was performed according to a standard arthritis protocol including T1 and fat-suppressed T2 weighted images and T1 weigthed fat-suppressed post gadolinium sequences. MRI images were evaluated by two musculoskeletal radiologists in consensus for the presence of synovitis, tenosynovitis, bone marrow edema and erosions. The readers were blinded for all patient information.

Results:

MR imaging of the MCP, PIP and/or DIP 2-5 joints of the hand was performed in 10 patients and 10 matched controls, MRI of the knee in 4 patients and 4 matched controls. A total amount of 62 painful joints were evaluated and 62 corresponding joints in the control group. Minimal synovitis was seen in one of the MCP joints in two of the arthralgia patients (3.2% of all painful joints) and in none of the control group (p=0.50). Bone marrow edema was not appreciated in the arthralgia patients, but a small amount of bone-marrow edema was seen in a MCP joint of a control (1.6% of total joints, p=1.00). Tenosynovitis and erosions were absent in both groups.

Conclusion:

Subclinical inflammation on MRI was not seen more often in painful joints in arthralgia patients than in joints of controls. No anatomical substrate was found for arthralgia in IBD patients.

References:

1.    Palm Ø, Bernklev T, Moum B, Gran JT. Non-inflammatory joint pain in patients with inflammatory bowel disease is prevalent and has a significant impact on health related quality of life. J. Rheumatol. 2005 Sep;32(9):1755–9.

 2. Orchard TR, Wordsworth BP, Jewell DP. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 1998 Mar;42(3):387-91.

3. de Vlam K, Mielants H, Cuvelier C, de Keyser F, Veys EM, de Vos M. Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. J Rheumatol 2000 Dec;27(12):2860-5.


Disclosure:

W. Stomp,
None;

L. K. P. M. Brakenhoff,
None;

F. A. van Gaalen,
None;

D. van der Heijde,
None;

H. H. Fidder,
None;

D. W. Hommes,
None;

M. Reijnierse,
None;

J. L. Bloem,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/magnetic-resonance-imaging-in-inflammatory-bowel-disease-patients-with-arthralgia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology